GT
NUS icon

Greenleaf Trust’s Nu Skin NUS Stock Holding History

Greenleaf Trust’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,139
Closed -$107K – 844
2024
Q2 		$107K Buy
+10,139
New +$128K ﹤0.01% 776
2022
Q2 		– Sell
-4,478
Closed -$214K – 762
2022
Q1 		$214K Sell
4,478
-953
-18% -$47.2K ﹤0.01% 712
2021
Q4 		$276K Buy
+5,431
New +$241K ﹤0.01% 627
2021
Q3 		– Sell
-4,476
Closed -$254K – 731
2021
Q2 		$254K Hold
4,476
– – ﹤0.01% 631
2021
Q1 		$237K Sell
4,476
-164
-4% -$8.93K ﹤0.01% 631
2020
Q4 		$253K Buy
4,640
+61
+1% +$3.21K ﹤0.01% 514
2020
Q3 		$229K Buy
+4,579
New +$217K ﹤0.01% 478
2018
Q4 		– Sell
-3,863
Closed -$318K – 535
2018
Q3 		$318K Buy
3,863
+1,098
+40% +$87.3K 0.01% 377
2018
Q2 		$216K Buy
+2,765
New +$214K ﹤0.01% 455

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Greenleaf Trust's NUS Position: Q3 2024 in Review

Greenleaf Trust sold out of Nu Skin (NUS) in Q3 2024, closing a stake of 10,139 shares — an estimated $107K sold.

Greenleaf Trust first reported a position in NUS in Q2 2018 and held it in 9 quarters. The position peaked at $318K in Q3 2018. 203 funds tracked by Wall St. Rank hold NUS as of Q3 2024.

  • Greenleaf Trust reported no remaining Nu Skin position as of Q3 2024 after selling out during the quarter.
  • Greenleaf Trust sold 10,139 Nu Skin shares in Q3 2024, an estimated $107K.
  • Greenleaf Trust first reported a position in Nu Skin in Q2 2018 and held it in 9 quarters.
  • Greenleaf Trust's Nu Skin position peaked at $318K in Q3 2018.
  • 203 funds tracked by Wall St. Rank held Nu Skin as of Q3 2024.

Based on Greenleaf Trust's 13F filing for Q3 2024, filed 22 Oct 2024.